Lishan Aklog

2021 - PAVmed

In 2021, Lishan Aklog earned a total compensation of $9.3M as Chairman of the Board and Chief Executive Officer at PAVmed, a 674% increase compared to previous year.

Compensation breakdown

Bonus$613,000
Salary$582,667
Stock Awards$8,026,260
Other$39,750
Total$9,261,677

Aklog received $8M in stock awards, accounting for 87% of the total pay in 2021.

Aklog also received $613K in bonus, $582.7K in salary and $39.8K in other compensation.

Rankings

In 2021, Lishan Aklog's compensation ranked 1,177th out of 12,415 executives tracked by ExecPay. In other words, Aklog earned more than 90.5% of executives.

ClassificationRankingPercentile
All
1,177
out of 12,415
91st
Division
Manufacturing
413
out of 5,505
93rd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
45
out of 801
94th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
23
out of 522
96th
Industry
Surgical and Medical Instruments and Apparatus
14
out of 327
96th
Source: SEC filing on May 2, 2022.

Aklog's colleagues

We found two more compensation records of executives who worked with Lishan Aklog at PAVmed in 2021.

2021

Dennis McGrath

PAVmed

Chief Financial Officer

2021

Brian deGuzman

PAVmed

Chief Medical Officer

News

You may also like